Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled…

Overview of attention for article published in BMC Surgery, August 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 61,265 followers.

RT @xtofero: The Norwegian NorPACT-1 RCT is currently recruiting with FOLFIRINOX as neoadjuvant for primary resectable PDAC and hope to bec…

RT @xtofero: The Norwegian NorPACT-1 RCT is currently recruiting with FOLFIRINOX as neoadjuvant for primary resectable PDAC and hope to bec…

RT @xtofero: The Norwegian NorPACT-1 RCT is currently recruiting with FOLFIRINOX as neoadjuvant for primary resectable PDAC and hope to bec…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.